Extrapyramidal side-effects in elderly patients exposed to selective serotonin reuptake inhibitors

Human Psychopharmacology

Volumn 12, Issue 2, 1997, Pages 139-143

  Gormley, Niall ^a   Watters, Liam ^a   Lawlor, Brian A ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

elderly; extrapyramidal side effects; Parkinson's disease

Indexed keywords

DOPAMINE; FLUOXETINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AGED; ARTICLE; BRAIN DISEASE; DOPAMINERGIC SYSTEM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FIRST PASS EFFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

EID: 0030906764     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199703/04)12:2<139::AID-HUP850>3.0.CO;2-D     Document Type: Article

References (19)

1. Arya, D. K. (1994). Extrapyramidal symptoms with selective serotonin reuptake inhibitors. British Journal of Psychiatry, 165, 728-733.
2. Baldwin, D., Finegerg, N. and Montgomery, S. (1991). Fluoxetine, fluvoxamine and extrapyramidal disorders. International Clinical Psychopharmacology, 6, 51-58.
3. Black, B. and Uhde, T. W. (1992). Acute dystonia and fluoxetine. Journal of Clinical Psychiatry, 53, 9.
4. Bouchard, R. H., Pourcher, E. and Vincent, P. (1989). Fluoxetine and extrapyramidal side-effects. American Journal of Psychiatry, 146, 1352-1353.
5. Castleden, C. M. and George, C. (1979). The effects of ageing on hepatic clearance of propranolol. British Journal of Clinical Pharmacology, 7, 49-54.
6. Choo, V. (1993) Paroxetine and extrapyramidal reactions. Lancet, 341, 624.
7. Committee of Safety of Medicines (1993). Dystonia and withdrawal symptoms with paroxetine. Current Problems in Pharmacovigilance, 19, 1.
8. Coulter, D. M. and Pillans, P. I. (1995). Fluoxetine and extrapyramidal side-effects. American Journal of Psychiatry, 152, 122-125.
9. De Blasi, A. and Mennini, T. (1982). Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats. Brain Research, 242, 361-364.
10. Fallon, B. A. and Liebowitz, M. R. (1991). Fluoxetine and extrapyramidal symptoms in CNS lupus. Journal of Clinical Psychopharmacology, 11, 147-148.
11. Marsden, C. D., Mindham, R. H. S. and Mackay, A. V. P. (1986). Extrapyramidal movement disorders produced by antipsychotic drugs. In: The Psychopharmacology and Treatment of Schizophrenia, Bradley, P. B. and Hirsh, S. R. (Eds), Oxford Medical Publications, pp. 340-402.
12. Meltzer, H. Y., Simonovic, M., Fang, V. S., Shyne, P. M. and Arora, R. I. (1979). Extrapyramidal side-effects and increased serum prolactin following fluoxetine, a new antidepressant. Journal of Neural Transmission, 45, 165-175.
13. Peuskens, J. on behalf of the Risperidone Study Group (1995). Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multi-centre, double blind, parallel group study versus haloperidol. British Journal of Psychiatry, 166, 712-726.
14. Recoppa, L., Welch, W. A. and Ware, M. R. (1990). Acute dystonia and fluoxetine. Journal of Clinical Psychiatry, 51, 487.
15. Scheepers, B. D. and Rogers, D. G. (1994). Dyskinesias following treatment with 5-HT reuptake inhibitors. Journal of Psychopharmacology, 8, 258-260.
16. Schihbuddin, L. and Rapport, D. (1994). Sertraline and extrapyramidal side-effects. American Journal of Psychiatry, 151, 288.
17. Stein, E. N. (1993). Increase of Parkinsonian disability after fluoxetine medication. Neurology, 43, 211-213.
18. Tate, J. L. (1989). Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. American Journal of Psychiatry, 146, 399-400.
19. Wils, V. (1992). Extrapyramidal symptoms in a patient treated with fluvoxamine. Journal of Neurology, Neurosurgery and Psychiatry, 55, 330-331.